A worldwide study of care and quality of life in atopic dermatitis
Looks at care, treatment and daily life of people with atopic dermatitis.
Plain-language title generated from the registry record
Registry title: Global Healthcare Study on Atopic Dermatitis
Key facts
- Where
- Zurich, SwitzerlandSee the site
Where in Switzerland
- University of ZurichZurich, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Julia Tatjana Maul
- Trial code
- NCT07659756
- Record updated
- 22 June 2026
- Original description
The Global Healthcare Study on Atopic Dermatitis (GHSAD) is an international, multicenter observational study hosted by the University of Zurich (UZH) investigating healthcare access, treatment patterns, disease severity, and quality of life in patients with atopic dermatitis. The study collects standardized clinical data from routine medical records to identify disparities in healthcare delivery and outcomes across different healthcare systems.Read full original descriptionShow less
Global Healthcare Study on Atopic Dermatitis
The Global Healthcare Study on Atopic Dermatitis (GHSAD) is an international, multicenter observational study hosted by the University of Zurich (UZH) investigating healthcare access, treatment patterns, disease severity, and quality of life in patients with atopic dermatitis. The study collects standardized clinical data from routine medical records to identify disparities in healthcare delivery and outcomes across different healthcare systems.
Inclusion: Signed General Consent Form, or equivalent document; Confirmed diagnosis of Atopic Dermatitis.
Exclusion: Inability to provide informed consent; Datasets with ambiguous or unclear diagnosis.